OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Dermatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil	958
Error in Author Name	178
Error in Author Surname in Byline	176
Melanoma Screening	144
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	127
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	117
Group Omitted From Article Byline	112
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	102
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	100
JAMA Dermatology	99
Assessment of Cutaneous Vasculitis and Quality of Life	94
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	94
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	80
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	75
Cutaneous Angiosarcoma	71
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement	69
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	69
Skin Cancer Care in US Veterans—Serving Those Who Served	67
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	66
Alopecia Areata	66
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis	64
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	58
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis	57
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	56
Disordered Eating in Hidradenitis Suppurativa	53

Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	53
Nicotinamide for Skin Cancer Chemoprevention	52
Perceptions of US-Based Muslim Patients of Their Dermatology Care	51
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	51
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	50
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	49
Patient-Reported Outcomes in Dermatology	47
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	47
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	47
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	46
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	44
Treatment of Kimura Disease With Dupilumab	44
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	44
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	43
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis	43
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	42
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	42
Ultraprocessed Food Intake and Psoriasis	41
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply	41
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	41
COVID-19 as a Risk Factor For Autoimmune Skin Disease	40
Errors in Abstract, Results, and Table 1	40
JAMA Dermatology	40
Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab	39
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes	39
Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation	39
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply	39
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa	39
Cooling Research Fever in Dermatology—The Role of Community Service—Reply	38
Methotrexate and Interstitial Lung Disease—Reply	37
The Quest for a More Accurate Diagnosis of Cellulitis	37
Foscarnet-Induced Penile Ulceration	36
Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma	36
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome	36
Lesbian, Gay, Bisexual, and Transgender Identity and Disclosure Among Dermatologists in the US	36
Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018	35
Antihypertensive Medications and Eczematous Dermatitis in Older Adults	35
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	35
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma	35
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	35
Multiple Papules and Nodules on the Face and Extremities	35
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones	34
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab	34
Error in Figure 4	34
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis	34
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics	33
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma	33
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	33
Incidence of and Risk Factors for Keratinocyte Carcinoma After Pediatric Solid Organ Transplant	32
A Firm Pigmented Plaque on the Forearm of a Child	32

Error in Figure 1	31
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario	31
Numerous Angiomatous Lesions in an Infant	31
High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease	31
JAMA Dermatology Peer Reviewers in 2022	31
Chloracne	31
Errors in Figure 2 and Table 2 Footnotes	31
Oral Lichenoid Lesions Associated With Mediastinal Mass and Hypogammaglobulinemia in a Middle-aged Man	31
A Tribute to Samuel Moschella	30
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021	30
Research Fever in Dermatology—A Symptom of a Larger Problem	30
Dermatologist Workforce Mobility	29
A Case of Unilateral Focal Hyperkeratosis	29
Error in Table	29
Legislative Efforts Restricting Care for Transgender People	29
Billing Patterns and Geographic Distribution of Dermatologist-Dermatopathologists in the US From 2013 to 2017	28
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa	28
Value-Driven Skin Cancer Surveillance for Transplant Recipients	28
Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure	28
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity	28
JAMA Dermatology	28
Red Papulonodules in a Kidney Transplant Recipient	27
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea	27
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa	27
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus	27
The Genomic and Phenotypic Landscape of Ichthyosis	27
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	27
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	27
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body	26
Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology	26
Error in Author Byline	26
Skin Cancer Risk Factors and Screening Among Asian American Individuals	26
Incidence and Prevalence of Morphea	26
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab	25
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity	25
Error in Table Footnote	25
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis	25
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma	25
Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence	24
Recurring Papules and Nodules on the Vulva	24
JAK2 Fusions in Adult Patients With Mycosis Fungoides and CD30 Lymphoproliferative Disorders	24
CLOVES Syndrome	24
Global Psoriasis Burden and Forecasts to 2050	24
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib	23
Errors in the Affiliations and Corresponding Author Sections	23
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa	22
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	22
Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis	22
Mendelian Randomization for Dermatology Research	22
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII	21
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion	21
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin	21
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention	21
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy	21
CLAPO Syndrome	21
Skin-Related Quality of Life During Autoimmune Bullous Disease Course	21
Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis	21
Palmar Fasciitis and Polyarthritis Syndrome	21
Annular Erythematous Eruption in a Pediatric Patient	20
Smooth, Firm, Skin-Colored Papules on the Nasal Dorsum	20
Acrodermatitis Enteropathica	20
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris	20
Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use	20
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease	20
Benign Familial Pemphigus in Skin of Color	20
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	20
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme	19
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors	19
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US	18
JAMA Dermatology Peer Reviewers in 2024	18
JAMA Dermatology	18
Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken	18
Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid	18
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis	17
Eruptive Xanthomas	17
The Importance of Hair in Black−White Race Relations	17
Fibromyalgia in Patients With Hidradenitis Suppurativa	17
Error in Text	17
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology	17
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata	16

Artificial Intelligence and Dermatology	16
Content Analysis of Patient-Reported Outcome Measures Used in Patients With Nail Conditions	16
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus	16
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy	16
Granulomatous Cheilitis in a Young Woman	16
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	16
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	16
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply	16
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age	16
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream	15
JAMA Dermatology	15
Rubella Virus–Associated Granulomas in Immunocompetent Adults—Possible Implications	15
Pott Puffy Tumor	15
A Reddish Semitransparent Tumor in an Adolescent Girl	15
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease	15
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis	15
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases	15
Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed	15
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab	15
Granulomatosis With Polyangiitis Presenting With Strawberry Gums	15
Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery	14
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease	14
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne	14
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	14
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	14
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	14
Improvement of Hailey-Hailey Disease With Topical Cinacalcet, 3%, Ointment	14
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis	14
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy	14
Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	14
Patient Perspectives on Living With Severe Prurigo Nodularis	14
Treatment of Netherton Syndrome With Abrocitinib	14
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	13
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	13
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	13
Pigmentary Changes in a Woman With Oral Lichen Planus	13
Tuberculous Mastitis	13
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	13
Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons	13
Error in Box	13
Generalized Micropapular Eruption in a Teenager	13
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	13
Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome	13
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	13
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma	13
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	13
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	12
Pyoderma Gangrenosum	12
Topical β-Blocker Wet Wrap Therapy for Amivantamab-Induced Scalp and Facial Necrosis	12
JAMA Dermatology	12
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	12
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	12
Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply	12
Reanalysis of Study After Removal of Participants in 1 Trial of Upadacitinib for Atopic Dermatitis	12
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay—Reply	12
Sunburn and Cutaneous Squamous Cell Carcinoma	12
Unusual Congenital Scalp Lesion in a Child	12
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	12
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	12
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome	12
Intralesional Certolizumab for Refractory Lupus Pernio	12
Onychomycosis	12
Arc-Shaped Furrow on the Forehead Extending From Linear Alopecia on the Vertex	12
Hereditary Leukonychia Associated With GJA1 Mutation	12
Clinical Features and Outcomes of Black Patients With Melanoma	12
Annular Cutaneous Lesion of the Neck	12
Treatment of Suspected Rubella Virus–Associated Granulomatous Dermatitis With Adalimumab	12
Olmsted Syndrome	12
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus	12
Genetic Variants Associated With Hidradenitis Suppurativa	12
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	12
JAMA Dermatology	12
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	12
Improving Outcomes in Chronic Graft-vs-Host Disease	11
Risk of Alopecia Areata After COVID-19	11
Cutaneous Anthrax	11
Navigating Melanoma In Situ in the Age of Overdiagnosis	11
Association Between Homelessness and Group A Streptococcus Skin and Soft Tissue Infections Among Hospitalized Dermatology Consult Patients	11
Clinical Data on Laboratory Testing for Patients Taking Systemic Immunomodulatory Agents	11
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion	11
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	11
Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum	11
Trichophyton mentagrophytes Internal Transcribed Spacer Genotype VIII	11
Association Between Low-Dose Methotrexate Exposure and Melanoma	11
Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS	11
Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid	11
Genital and Perigenital “W”-Shaped Telangiectasias in Women With Limited Cutaneous Systemic Sclerosis	11
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus	11
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19	11
Measuring the Carbon Footprint of Dermatology	10
Use of Dupilumab to Manage Antibody-Drug Conjugate–Induced Cutaneous Toxicities	10
Response of Darier Disease Following Treatment With Baricitinib	10
Tzanck Smear of Ulcerated Plaques	10
Immunostimulatory Herbal Intake and Autoantibody Positivity in Dermatomyositis	10
Hunter Syndrome	10